CRR (@crrdmu) 's Twitter Profile
CRR

@crrdmu

Twitter account for the Centre for Reproduction Research
@dmuleicester

ID: 834420299982573570

linkhttps://linktr.ee/CRR_DMU calendar_today22-02-2017 15:11:17

3,3K Tweet

980 Takipçi

513 Takip Edilen

CRR (@crrdmu) 's Twitter Profile Photo

Looking to do a post-doc in social studies relating to reproduction? Recently completed your PhD in the UK? We are taking expressions of interest. Email [email protected] before 1 Feb for a discussion in the first instance. More info on the scheme: warwick.ac.uk/fac/cross_fac/….

CRR (@crrdmu) 's Twitter Profile Photo

Fantastic piece from CRR member Kate Pleace using her expertise to review the new ESHRE POI guidelines - exploring what is new in the guidelines and the context in which practitioners will be trying to deliver them.

CRR (@crrdmu) 's Twitter Profile Photo

A reminder the CRR is taking expressions of interest for ESRC-funded post-doctoral fellowships. Please get in touch by 1 February.

Dr Kriss Fearon (@krissfearon) 's Twitter Profile Photo

Shana Riethof visited the CRR while writing up her thesis. This blog is on Noninvasive prenatal testing in Belgium: how to make technologies reliable #nipt …uctionresearch962893217.wordpress.com/2025/03/05/non…

PRECASdmu (@precasdmu) 's Twitter Profile Photo

Delighted to announce that the PRECAS Project PI, Prof Cathy Herbrand, is giving her inaugural lecture on Tuesday 25th March (in person only). This is to celebrate her promotion to professor. There will be a drinks reception afterwards, all welcome. eventbrite.co.uk/e/family-makin…

CRR (@crrdmu) 's Twitter Profile Photo

Today we're delighted to welcome Rachel Arkell to talk about her research on sodium valproate and pregnancy. SV is a potentially lifesaving medication for epilepsy and BPD. Its association with foetal risk raises questions of consent, autonomy and risk in pregnancy prevention.

Today we're delighted to welcome <a href="/R_Arkell/">Rachel Arkell</a> to talk about her research on sodium valproate and pregnancy. SV is a potentially lifesaving medication for epilepsy and BPD. Its association with foetal risk raises questions of consent, autonomy and risk in pregnancy prevention.